Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes-Reference-Cited by-同舟云学术

Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes

Published:2016-05-17 Issue:5 Volume:17 Page:744
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Saisho Yoshifumi

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/17/5/744/pdf

Reference29 articles.

1. International Diabetes Federation IDF Diabetes Atlas, 7th ed.http://www.idf.org/diabetesatlas

2. β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes

3. Type 1 diabetes

4. Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis

5. β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Fasting C-peptide to Glucose Ratio and Triglyceride Glucose Index as Markers for β-Cell Dysfunction and Insulin Resistance in Patients With Type 2 Diabetes on Insulin Therapy;Cureus;2024-08-09

2. Abdominal Obesity–Metabolic Syndrome 3 Misclassified as Type 1 Diabetes Mellitus;JCEM Case Reports;2024-07-24

3. Dietary Cholest-4-en-3-one, a Cholesterol Metabolite of Gut Microbiota, Alleviates Hyperlipidemia, Hepatic Cholesterol Accumulation, and Hyperinsulinemia in Obese, Diabetic db/db Mice;Metabolites;2024-06-03

4. Effects of rapid or slow body weight reduction on glucose tolerance during equivalent weight loss in rats fed high-fat diet;The Journal of Physical Fitness and Sports Medicine;2024-05-25

5. Predictive value of postprandial C-peptide for utilizing multiple daily injection therapy in type 2 diabetes;Endocrine;2024-04-15